EVALUASI PENGGUNAAN OBAT ANTIDIABETIK ORAL PADA PASIEN DIABETES MELITUS TIPE 2 MENGGUNAKAN METODE ATC/DDD DAN DU 90%

  • Nurshalati Tahar Universitas Islam Negeri Alauddin Makassar
    (ID)
  • Alifia Putri Febriyanti
  • Munifah Wahyuddin
  • Syahifah Auliyah Hasti

Abstract

Diabetes mellitus is a chronic metabolic disease caused by the pancreas not producing enough insulin or not being able to use the required insulin effectively. Evaluate the use of oral antidiabetic drugs using ATC Diabetes mellitus is a chronic metabolic disease caused by the pancreas not producing enough insulin or not being able to use the required insulin effectively. Evaluate the use of oral antidiabetic drugs using ATC / DDD and DU 90% methods. Oral antidiabetic used in Makassar Hospita Hospital there are 3 types of metformin as many as 1020 units with a dose per unit that is 500 mg with a total use of 601000 mg 99.56%, more than 48 units with a perunit dose of 60 mg with a total dose of 2520 mg 0 , 41%, the last is 41 units of glimepiride with a perunit dose of 2 mg with a total use of 82 0.01%. Of the 3 types of oral antidiabetic, 3 usage patterns were obtained, namely 84% single metformin, 9% metformin + gliclazide combination pattern and 7% metformin + glimepirid combination. Included in the 90% DU segment or included in the list of incoming drugs is collected 90% of drug use after being sorted from the highest and highest percentage of drug use for compilation and low use is the use of metformin, using the correct use of drugs according to the choice, right dose, right delivery time, exact route and right information.

Downloads

Download data is not yet available.

References

Al-Imam Abul Fida Isma’il Ibnu Katsir ad-Dimasyqi. Terjemahan Tafsir Ibnu Katsir. Bandung: Sinar Baru al-Gensindo, 2013.

Al-qur’an dan Terjemahannya.Kementrian Agama Republik Indonesia. 2013.

Aristika, Dian. Deskripsi karakteristik penderita, lama dirawat (los) dan

epidemiologi penyakit diabetes mellitus pada pasien jkn di rsud

tugurejo semarang triwulan i tahun 201. semarang. 2014.

Campbell, dkk. The mode of action and clinical pharmacology of gliclazide: a review. France : UK.2015.

Demchuk, M., dkk. Nationwide trends in antidiabetic drugs (type-2) utilization,Ukraine: International Journal of Green Pharmacy, 2018.

Dominic, A. Study Of Drug Use Evaluation On Oral Antihyperglycemic Agents In Type 2 Diabetes Melliitus And Their Potential Drug-Drug Interactions.the Oxford College of Pharmacy. Inggris: Oxford University, 2016.

Elhamili, dkk. Pharmaceutical Evaluation of Type II Oral Antidiabetic Agent.Libya:Ijpr, 2014.

Enggar. Gambaran Faktor Resiko Terjadinya Diabetes Melitus Pada Penderita Diabetes Melitus Tipe 2.Surakarta: Universitas muhammadiyah Surakarta. 2019.

Ghoffar Muhammad. Tafsir Ibnu Katsir. Bogor : Pustaka Imam Syafi'i, 2004.

Hongdiyanto, arnold., dkk. Evaluasi Kerasionalan Pengobatan Diabetes MelitusTipe 2 pada Pasien Rawat Inap di RSUP Prof. Dr.R. D. Kandou Manado Tahun 2013. Manado: Universitas Sam Ratulangi, 2015.

Hasrianna, dkk. Monitoring Use of Antibiotics with ATC/DDD and DU 90% Method in Abepura Hospital Jayapura, Indonesia. Sumedang: Indonesian Journal of Clinical Pharmacy, 2015.

Kementrian Kesehatan RI. "Pusat Data Dan Informasi Diabetes Melitus". (14 April 2014).

Islam, Z., dkk. The Analisys Different Of Treatment Diabetes Melitus Type II On General Patients And National Health Insurrance Patients ( Bpjs ). Jakarta: universitas Muhammadiyah Prof. Hamka, 2014.

Joddy, dkk. Kejadian Efek Samping Potensial Terapi Obat Anti Diabetes Pasien Diabetes Melitus Berdasarkan Algoritma Naranjo. Malang: Universitas Brawijaya

Jonathan, Kevin, dkk. Pola Penggunaan Antidiabetek Oral Pasien Diabetes Melitus Tipe 2 di Bagian Penyakit Dalam RSUD Kota Bandung Tahun 2017. Bandung: Universitas Padjajaran. 2017.

Lahiry, S., dkk. Analyzing Antidiabetes Drug Prescriptions With World Health Organization Anatomical Therapeutic Chemical/Defined Daily Dose Index to Assess Drug Utilization Pattern in Elderly Population of Rural Eastern India. India: Integrative Medicine Insights, 2017.

Lei Chen, T. L. Inferring anatomical therapeutic chemical (ATC) class of drugs using shortest path and random walk with restart algorithms.molecular basis of diasease, 2017

Mahmudah, F. dkk. Study of the Use of Antibiotics with ATC/DDD System and DU 90% in Digestive Surgery in Hospital in Bandung. Bandung: Indonesian Journal of Clinical Pharmacy, 2016.

Mazzaglia, G., & Mol, P. Drug utilization research and risk management. Belanda: University Of Groningen, 2016.

Nnaemeka, R., dkk. Future Journal of Pharmaceutical Sciences Utilization study of antidiabetes medicines at a tertiary care hospital in Nigeria. Nigeria:Future Journal of Pharmaceutical Sciences, 2017.

Nyoman Wijaya, I. dkk.Profil Penggunaan Obat Pada Pasien Diabetes Melitus Di Puskesmas Wilayah Surabaya Timur. Surabaya: Jurnal Farmasi Komunitas, 2015.

Pengurus Besar Perkumpulan Endokrinologi Indonesia. Konsensus Pengendalian dan Pencegahan Diabetes Melitus Tipe 2 di Indonesia.Jakarta: Perkeni, 2015.

Rasdianah, N. dkk. The Description of Medication Adherence for Patients of Diabetes Mellitus Type 2 in Public Health Center Yogyakarta.Yogyakarta: Indonesian Journal of Clinical Pharmacy, 2016.

Richardo, Betteng. Analisis Faktor Resiko Penyebab Terjadinya Diabetes Melitus Tipe 2 Pada Wanita Usia Produktif Dipuskesmas Wawonas. Manado: Fakultas Kedokteran Universitas Sam Ratulangi. 2014.

Sastroasmoro, dan Sofyan Ismael. 2014. Dasar-dasar Metodologi Penelitian Klinis, in : Pemilihan subjek penelitian dan Desain Penelitian. jakarta: Sagung seto.

Setiyorini, Erni., dkk. Hubungan Lama Menderita dan Kejadian Komplikasi dengan Kualitas Hidup Lansia Penderita Diabetes Melitus Tipe 2. Blitar: STIKes Patria Husada, 2017.

Sholih, M. G., dkk. Rasionalitas Penggunaan Antibiotik di Salah Satu Rumah Sakit Umum di Bandung. Bandung:Indonesian Journal of Clinical Pharmacy, 2015.

World Health Organization. 2013. Guidelines for and DDD assignment. WHO Collaborating Centre For Drug Statistic Methodology.

World Health Organization. 2014. Introduction Drug UtilizationResearch. Norway, Oslo: WHO Publication, 2014.

World Health Organization. 2019. Guidelines for and DDD assignment. WHO Collaborating Centre For Drug Statistic Methodology.

Published
2020-12-25
Abstract viewed = 2220 times